Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trialRobin Kate Kelley, Ming‐Huang Chen, Junji Furuse et al.|The Lancet|2023Cited by 1k
<i>Nuclear Factor Erythroid 2 Related Factor 2</i> and Mitochondria Form a Mutually Regulating Circuit in the Prevention and Treatment of Metabolic SyndromeJiawei Zhang, Jiankang Liu, Guanfei Zhang et al.|Antioxidants and Redox Signaling|2024Cited by 17